FeesSafety
Pluang+

Whirlpool reports Q3 losses amid tough market, plans price hikes and cost cuts for 2027 recovery

Company Fundamentals
26 Oct 2026, 23:05 WIB
PRNewsWire
View Source
Bearish
Whirlpool reports Q3 losses amid tough market, plans price hikes and cost cuts for 2027 recovery

Whirlpool reported a Q3 GAAP net loss of $249 million with a loss per share of $3.80, impacted by macroeconomic challenges and a trade customer bankruptcy in Latin America. The company is implementing price increases in North and Latin America and structural cost reductions to improve margins, with ongoing EBIT margin at 2.6%. For 2026, Whirlpool expects a GAAP loss per share of $4.95 but aims for positive cash flow of around $300 million and reduced net debt below $4.5 billion by year-end. These measures set a foundation for operational improvements and margin recovery in 2027 despite a slower-than-expected pace.

Whirlpool Corporation's third-quarter results provide context for consumer cyclical sector activity on Pluang. For readers following this sector, here is Pluang's market snapshot as of Oct 27, 2026 03:11 WIB: Among 134 priced US consumer cyclical stocks, 66 rose and 67 fell today. Harley-Davidson Inc (HOG) gained 6.47% to USD 29.11 with a typical hold time of 93 days, contrasting with Mercadolibre Inc (MELI), which dropped 8.07% to USD 1,664.00 and has a longer hold time of 119 days. Best Buy Co Inc (BBY) rose 6.01% to USD 99.78 but saw 99% of Pluang order activity on the sell side, with a shorter typical hold time of 65 days.

More News

Exodus Movement to announce Q3 2026 financial results on Nov 9 with a webcast.

Exodus Movement to announce Q3 2026 financial results on Nov 9 with a webcast.

Exodus Movement, a self-custodial finance and payments platform, will release its third quarter 2026 financial results after market close on November 9, 2026. The company will host a webcast at 5:00 PM ET the same day to discuss the results. Founded ...

Company Fundamentals
Neutral
1 hour ago
Onco360 named national pharmacy partner for AstraZeneca's lung cancer drug Zegfrovy.

Onco360 named national pharmacy partner for AstraZeneca's lung cancer drug Zegfrovy.

Onco360, a leading independent specialty pharmacy, has been selected by AstraZeneca as a national pharmacy partner for Zegfrovy (sunvozertinib), a treatment for advanced non-small cell lung cancer with EGFR exon 20 insertion mutations. Zegfrovy has s...

Market News
Bullish
1 hour ago
S4A IT Solutions joins SAP PartnerEdge program, boosting its SAP consulting capabilities.

S4A IT Solutions joins SAP PartnerEdge program, boosting its SAP consulting capabilities.

S4A IT Solutions has been accepted into the SAP PartnerEdge program, marking a key milestone in its growth. This partnership enhances S4A's ability to help organizations maximize their SAP investments, especially in areas like asset management and su...

Market News
Bullish
2 hours ago
SEC policy shifts and rising shareholder activism shape 2027 proxy season preparations for public companies

SEC policy shifts and rising shareholder activism shape 2027 proxy season preparations for public companies

Public companies are facing new challenges for the 2027 proxy season due to changes in SEC policies, evolving shareholder activism strategies, and shifts in institutional investor voting. A virtual roundtable on October 28 will gather experts to disc...

Market News
Neutral
3 hours ago
Gogo to release Q3 2026 earnings on Nov 6 with a conference call for analysts.

Gogo to release Q3 2026 earnings on Nov 6 with a conference call for analysts.

Gogo Inc., a leading provider of in-flight broadband connectivity, announced it will report its third quarter 2026 financial results on November 6, 2026, before the market opens. The company will hold a conference call with financial analysts the sam...

Company Fundamentals
Neutral
3 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App